NABR Celebrates CITES Committee's Decision to Not Halt Trade in Cambodian Long-tailed Macaques

NABR Celebrates CITES Decision on Long-tailed Macaques

The National Association for Biomedical Research (NABR) has expressed its approval after the CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora) Permanent Committee made the significant decision not to impose a trade ban on Cambodian long-tailed macaques (Macaca fascicularis) on February 5, 2025. This ruling from the international committee highlights the collective commitment to a fair, research-based evaluation process that stands firmly against misinformation propagated by radical activist groups.

Importance of Scientific Assessment

Japan initiated the call for a deferral regarding the ban on trade at a future CITES meeting, garnering support from several nations including the United States, Canada, and Kuwait. Throughout this meeting in Geneva, Switzerland, not a single country backed the Secretariat's previous recommendation, which suggested a halt on trade based on erroneous claims regarding Cambodia’s macaque exports. Instead, several countries proactively emphasized the importance of assessing recently submitted information from Cambodia before any decisive actions.

The committee's decision now allows for in-depth evaluations by the CITES Secretariat and provides the opportunity for a formal delegation to visit Cambodia for oversight, ensuring that procedures remain transparent and fact-based. Moreover, this careful approach grants the Committee on Natural Resources in the U.S. House of Representatives time to complete its ongoing review and oversight of the matter.

A Win for Scientific Integrity

Matthew R. Bailey, president of NABR, commented, "The acknowledgment from the CITES Permanent Committee that careful, evidence-based considerations are essential for significant decisions is commendable. Biomedical research relies heavily on the availability of long-tailed macaques to conduct vital studies, including advancements in treatments for infectious diseases, cancer, and other pressing health issues. The international community's decision to reject an unfounded trade suspension is a tremendous victory for scientific integrity and public health."

NABR remains committed to advocating for scientifically-based policies that support ethical biomedical research. Bailey further stated, "We intend to collaborate with global stakeholders to promote transparency, uphold scientific integrity, and ensure that the responsible use of research animals continues to drive lifesaving medical advancements."

About NABR

Founded in 1979, the National Association for Biomedical Research (NABR) is the sole nonprofit organization under the 501(c)(6) category, dedicated to fostering effective public policies surrounding the humane use of animals in biomedical research, education, and testing. Its members include over 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology firms, patient advocacy groups, and several academic and professional organizations that depend on responsible and humane animal research, ultimately enhancing the health of both people and animals across the globe.

To learn more about NABR, visit nabr.org.